Coronary heart disease 1

Common Name(s)

Coronary heart disease 1

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Coronary heart disease 1" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Coronary heart disease 1" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Coronary heart disease 1" returned 58 free, full-text research articles on human participants. First 3 results:

Serum Gamma-glutamyl Transferase Concentration Within the Reference Range is Related to the Coronary Heart Disease Risk Prediction in Korean Men: Analysis of the Korea National Health and Nutrition Examination Survey (V-1, 2010 and V-2, 2011).
 

Author(s): Kyung-Sun Han, Doo-Yeoun Cho, Young-Sang Kim, Kyu-Nam Kim

Journal: Chin. Med. J.. 2015 Aug;128(15):2006-11.

 

Limited data exist on the association of serum gamma-glutamyl transferase (GGT) level within the reference range with the increased risk of coronary heart disease (CHD) prediction in men. The study examined the association between serum GGT concentration within the reference range ...

Last Updated: 3 Aug 2015

Go To URL
Serum CD121a (Interleukin 1 Receptor, Type I): A Potential Novel Inflammatory Marker for Coronary Heart Disease.
 

Author(s): Zhengxia Liu, Mengyao Zhang, Jin Wu, Ping Zhou, Ying Liu, Yucheng Wu, Yujiao Yang, Xiang Lu

Journal:

 

Inflammation is now believed to be responsible for coronary heart disease (CHD). This belief has stimulated the evaluation of various inflammatory markers for predicting CHD. This study was designed to investigate the association between four inflammatory cytokines (CD121a, interleukin ...

Last Updated: 23 Jun 2015

Go To URL
Interaction effects between Paraoxonase 1 variants and cigarette smoking on risk of coronary heart disease in a Singaporean Chinese population.
 

Author(s): Yi Han, Rajkumar Dorajoo, Tingjing Ke, Burger Ayala, Xuling Chang, Chiea-Chuen Khor, Rob M van Dam, Jian-Min Yuan, Woon-Puay Koh, Jianjun Liu, Daniel Y T Goh, Yechiel Friedlander, Chew-Kiat Heng

Journal: Atherosclerosis. 2015 May;240(1):40-5.

 

Paraoxonase 1 (PON1) plays an important role in reducing the risk of coronary heart disease (CHD). Smoking is known to reduce PON1 activity. We aimed to investigate the effects of interactions between PON1 variants and smoking on CHD in the Singaporean Chinese population.

Last Updated: 13 Apr 2015

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Coronary heart disease 1" returned 2 free, full-text review articles on human participants. First 3 results:

The timing hypothesis and hormone replacement therapy: a paradigm shift in the primary prevention of coronary heart disease in women. Part 1: comparison of therapeutic efficacy.
 

Author(s): Howard N Hodis, Wendy J Mack

Journal: J Am Geriatr Soc. 2013 Jun;61(6):1005-10.

 

The long-held belief that outcome data from intervention trials in men are generalizable to women has created the framework in which the primary prevention of coronary heart disease (CHD) in women is viewed, but over the past decade, data have accumulated to refute such a supposition ...

Last Updated: 18 Jun 2013

Go To URL
Coronary heart disease associated with the use of human immunodeficiency virus (HIV)-1 protease inhibitors: report of four cases and review.
 

Author(s): M Duong, M Buisson, Y Cottin, L Piroth, I Lhuillier, M Grappin, P Chavanet, J E Wolff, H Portier

Journal: Clin Cardiol. 2001 Oct;24(10):690-4.

 

Four cases of human immunodeficiency virus (HIV)-infected patients who developed coronary heart disease (CHD) while under treatment with a protease inhibitor (PI) are described, and the epidemiologic and clinical features of 18 cases reported in the literature are analyzed. Cardiac ...

Last Updated: 11 Oct 2001

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in Genetics Home Reference.

There are currently no related results available in GeneReviews.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

GLP-1 Loading During Elective Percutaneous Coronary Intervention
 

Status: Recruiting

Condition Summary: Angina Pectoris; Myocardial Infarction; Reperfusion Injury; Coronary Heart Disease

 

Last Updated: 27 Apr 2015

Go to URL
Dynamic Changes in SDF-1α Levels in Acute and Stabilized Heart Disease
 

Status: Recruiting

Condition Summary: Atrial Fibrillation; Ischemic Heart Disease; Congestive Heart Failure

 

Last Updated: 19 Mar 2016

Go to URL
Is Glucagon-like Peptide-1 Insufficiency a Residual Risk in Coronary Artery Disease?
 

Status: Recruiting

Condition Summary: Coronary Artery Disease

 

Last Updated: 8 May 2016

Go to URL